Type 1 diabetes is an autoimmune disease where the pancreas produces little or no insulin, resulting in elevated blood sugar levels. Current standards of care involve insulin therapy and blood glucose monitoring but do not cure the underlying condition.
Potential cures in development include cell therapies to restore insulin-producing cells, gene therapies to modulate the immune system, and approaches to encapsulate therapeutic cells. Several clinical trials are underway exploring these methods, with the goal of restoring natural insulin production without ongoing treatment.
While progress has been made, an FDA-approved therapy definitively meeting the criteria for a cure remains elusive as of March 2024. This question asks whether such a curative treatment will cross that milestone by the beginning of 2032.
References:
| Indicator | Value |
|---|---|
| Stars | ★★★☆☆ |
| Platform | Metaculus |
| Number of forecasts | 16 |
Type 1 diabetes is an autoimmune disease where the pancreas produces little or no insulin, resulting in elevated blood sugar levels. Current standards of care involve insulin therapy and blood glucose monitoring but do not cure the underlying...